Almanac Health Boosts Clinical AI Trust with $10M Funding
April 27, 2026, 4:45 am
Location: United States, California, Menlo Park
Employees: 51-200
Founded date: 2000
Almanac Health secured $10 million in a seed round, bringing total funding to nearly $12 million. The company introduces research-validated clinical AI. It aims to empower physicians with specialist-grade knowledge. The platform integrates seamlessly into existing EHR systems. It operates under strict institutional controls. Almanac Health prioritizes evidence-based decision support. Founder Cyril Zakka, MD, pioneered Retrieval-Augmented Generation (RAG) for clinical medicine. This approach anchors AI in trusted medical knowledge. Funding will expand the team and advance privacy-focused R&D. Almanac addresses a critical need for reliable, trustworthy AI in healthcare. It moves beyond unverified models to deliver accountable solutions. The company is actively setting a new standard for clinical AI validation.
Almanac Health launches a new era for clinical artificial intelligence. The company recently secured a $10 million seed funding round. This investment elevates its total capital to nearly $12 million. F-Prime led the round. General Catalyst and Lightspeed Venture Partners also participated. General Catalyst previously led Almanac's pre-seed efforts. This significant backing signals strong confidence in its mission. Almanac Health aims to revolutionize physician support. It focuses on delivering trusted, evidence-based AI directly to the point of care.
Cyril Zakka, MD, founded Almanac Health. He brings a unique blend of clinical insight and technical expertise. Dr. Zakka is a physician-researcher from Stanford. There, he developed pioneering AI methodologies. He created one of the first Retrieval-Augmented Generation (RAG) systems for clinical medicine. This foundational work was published in NEJM AI. It became one of the journal's most-cited papers. Dr. Zakka’s contributions established a new standard. He demonstrated how to ground AI in verified medical knowledge. This experience also includes leading health AI initiatives at Hugging Face. His vision now drives Almanac Health.
The platform distinguishes itself through its core technology. Almanac Health utilizes RAG to process and present medical information. Unlike many "black box" AI solutions, RAG references specific, peer-reviewed data. This method ensures accuracy and transparency. It prevents the AI from generating unverified or hallucinated information. The system anchors its generative capabilities in trusted medical sources. This provides clinicians with reliable insights. It helps avoid the pitfalls of generalist AI models. Trust becomes paramount in clinical settings. Almanac Health builds this trust by design.
Integration into existing healthcare infrastructure is a core strength. Almanac's software connects directly with Electronic Health Record (EHR) systems. This seamless integration ensures minimal disruption to clinical workflows. Physicians access specialist-grade intelligence without leaving their primary systems. The platform delivers actionable insights at critical decision points. This "physician-centric" design combats burnout. It avoids the friction often caused by poorly integrated technologies. The goal is to augment, not complicate, a clinician's day.
Almanac Health commits to rigorous validation. It is not deploying a finished product untested. Instead, the platform undergoes continuous evaluation. This happens within academic medical centers. This process ensures accountability and alignment. Health system leaders demand high standards. Almanac meets these expectations through thorough testing. The system operates under strict institutional governance. This allows hospitals to maintain authority. They control how AI-generated intelligence is utilized within their walls. This careful, measured approach builds essential confidence.
The funding fuels strategic growth and development. Almanac Health will expand its cross-functional team. This includes experts in clinical medicine, AI research, and health systems infrastructure. A significant portion of the investment targets R&D. The focus remains on privacy and system reliability. Almanac ensures institutional data remains secure. It guarantees the AI delivers consistently actionable insights. Investors recognize this as crucial. They view Almanac as building the "next generation" of healthcare infrastructure. This new model aligns incentives with patient outcomes. It moves beyond pharmaceutical advertising or administrative metrics.
The healthcare AI landscape is crowded. Many tools promise revolutionary change. Few, however, meet rigorous evidence standards. Almanac Health enters this market at a pivotal moment. The industry has moved past the initial hype of large language models. It now demands clinical evidence. Almanac addresses this directly. It leverages Dr. Zakka's foundational RAG work. This commercializes a methodology already proven viable. It is not just another startup. It represents the maturation of clinical AI itself.
Almanac Health envisions a future of "Health Assurance." In this model, technology provides accountability and alignment. It drives systemic transformation within healthcare. The company's steadfast focus remains clear. It builds a standard for clinical AI. This standard is as rigorous as the peer-reviewed science it draws upon. This commitment positions Almanac as a leader. It will shape the future of medical decision support. It empowers clinicians with trustworthy, evidence-based intelligence. Almanac Health elevates patient care through advanced, responsible AI.
Almanac Health launches a new era for clinical artificial intelligence. The company recently secured a $10 million seed funding round. This investment elevates its total capital to nearly $12 million. F-Prime led the round. General Catalyst and Lightspeed Venture Partners also participated. General Catalyst previously led Almanac's pre-seed efforts. This significant backing signals strong confidence in its mission. Almanac Health aims to revolutionize physician support. It focuses on delivering trusted, evidence-based AI directly to the point of care.
Cyril Zakka, MD, founded Almanac Health. He brings a unique blend of clinical insight and technical expertise. Dr. Zakka is a physician-researcher from Stanford. There, he developed pioneering AI methodologies. He created one of the first Retrieval-Augmented Generation (RAG) systems for clinical medicine. This foundational work was published in NEJM AI. It became one of the journal's most-cited papers. Dr. Zakka’s contributions established a new standard. He demonstrated how to ground AI in verified medical knowledge. This experience also includes leading health AI initiatives at Hugging Face. His vision now drives Almanac Health.
The platform distinguishes itself through its core technology. Almanac Health utilizes RAG to process and present medical information. Unlike many "black box" AI solutions, RAG references specific, peer-reviewed data. This method ensures accuracy and transparency. It prevents the AI from generating unverified or hallucinated information. The system anchors its generative capabilities in trusted medical sources. This provides clinicians with reliable insights. It helps avoid the pitfalls of generalist AI models. Trust becomes paramount in clinical settings. Almanac Health builds this trust by design.
Integration into existing healthcare infrastructure is a core strength. Almanac's software connects directly with Electronic Health Record (EHR) systems. This seamless integration ensures minimal disruption to clinical workflows. Physicians access specialist-grade intelligence without leaving their primary systems. The platform delivers actionable insights at critical decision points. This "physician-centric" design combats burnout. It avoids the friction often caused by poorly integrated technologies. The goal is to augment, not complicate, a clinician's day.
Almanac Health commits to rigorous validation. It is not deploying a finished product untested. Instead, the platform undergoes continuous evaluation. This happens within academic medical centers. This process ensures accountability and alignment. Health system leaders demand high standards. Almanac meets these expectations through thorough testing. The system operates under strict institutional governance. This allows hospitals to maintain authority. They control how AI-generated intelligence is utilized within their walls. This careful, measured approach builds essential confidence.
The funding fuels strategic growth and development. Almanac Health will expand its cross-functional team. This includes experts in clinical medicine, AI research, and health systems infrastructure. A significant portion of the investment targets R&D. The focus remains on privacy and system reliability. Almanac ensures institutional data remains secure. It guarantees the AI delivers consistently actionable insights. Investors recognize this as crucial. They view Almanac as building the "next generation" of healthcare infrastructure. This new model aligns incentives with patient outcomes. It moves beyond pharmaceutical advertising or administrative metrics.
The healthcare AI landscape is crowded. Many tools promise revolutionary change. Few, however, meet rigorous evidence standards. Almanac Health enters this market at a pivotal moment. The industry has moved past the initial hype of large language models. It now demands clinical evidence. Almanac addresses this directly. It leverages Dr. Zakka's foundational RAG work. This commercializes a methodology already proven viable. It is not just another startup. It represents the maturation of clinical AI itself.
Almanac Health envisions a future of "Health Assurance." In this model, technology provides accountability and alignment. It drives systemic transformation within healthcare. The company's steadfast focus remains clear. It builds a standard for clinical AI. This standard is as rigorous as the peer-reviewed science it draws upon. This commitment positions Almanac as a leader. It will shape the future of medical decision support. It empowers clinicians with trustworthy, evidence-based intelligence. Almanac Health elevates patient care through advanced, responsible AI.